Skip to content

Efficacy of Compassion Focused Therapy in Group for Posttraumatic Stress Disorder

Group Compassion Focused Therapy for Posttraumatic Stress Disorder

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03154931
Acronym
GCFT-PTSD
Enrollment
80
Registered
2017-05-16
Start date
2015-10-31
Completion date
2018-10-31
Last updated
2017-05-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

PTSD

Keywords

PTSD, CBT, CFT, compassion, shame, guilty, self-criticism

Brief summary

The purpose of this study is to determine the efficacy of a 8-week program of Compassion Focused Therapy in Group comparing to Supportive Cognitive Behavioral Therapy in Group for patients with Posttraumatic Stress Disorder.

Detailed description

This study will be a randomized clinical trial with two parallel groups, with two models of treatment: Group 1 - Control Group - will receive CBT Supportive Group (CBT-SG) and Group 2 - Experimental Group - will receive Compassion Focused Therapy (CFT-G). Will be attended in total, the maximum of 80 patients, with 40 patients in each arm (CBT-SG versus CFT-G). Both groups will be formed by at least eight patients and a maximum of twelve patients who receive eight weekly sessions with an hour and a half each session, and the total duration of treatment will be eight weeks. The groups will be closed, that is, after the start will not be permitted to input any more participants. The experimental group (CFT-G) will be structured and the control group (CBT-SG) will be unstructured, and free format. All patients will be assessed through self-report scales, within three distinct phases: Assessment I - Initial (before therapy); Assessment II - Final (after therapy); Assessment III - Follow-up (after 3 months of therapy ending). All groups will be led by a principal therapist and co-therapist. All sessions will be recorded for later evaluation of the researcher responsible for the research.

Interventions

OTHERCBT-SG

To support the group.

OTHERCFT-G

Teach compassionate skills.

Sponsors

University of Sao Paulo General Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Clinical Administered PTSD Scale 5 Monthly version Criteria A and \>30 points

Exclusion criteria

* Suicidal patients and/or severe automutilation behavior and/or psychotic symptoms and/or lack of event memory.

Design outcomes

Primary

MeasureTime frameDescription
Clinical Administered Posttraumatic Stress 5up to 8 weeks40% decrease

Secondary

MeasureTime frameDescription
Outcome Questionnaire 45up to 8 weeks50% decrease
Davidson Trauma Scaleup to 8 weeks40% decrease
Beck Depression Inventoryup to 8 weeksfinal rating \<20.
Beck Anxiety Inventoryup to 8 weeksfinal rating \<19.
Connor Davidson Resilienceup to 8 weeks50% increase
Self Compassion Scaleup to 8 weeks50% increase
Other as a Shame Scaleup to 8 weeks50% decrease
Functions of Self Critical Scaleup to 8 weeks50% decrease
Beck Hopelessness Scaleup to 8 weeksfinal rating \<9.

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026